LXEO

Lexeo Therapeutics, Inc.

15.48 USD
-0.16 (-1.02%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Lexeo Therapeutics, Inc. stock is up 3.2% since 30 days ago. The next earnings date is Aug 21, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a red month, as 0% of the previous 1 June’s closed higher than May. 100% of analysts rate it a buy.

About Lexeo Therapeutics, Inc.

We are a clinical stage genetic medicine company dedicated to transforming healthcare by applying pioneering science to fundamentally change how disease is treated. Our principal executive offices are located at 345 Park Avenue South, Floor 6, New York, New York.

  • Baird
    Thu Jun 13, 05:13
    buy
    initial
  • HC Wainwright & Co.
    Thu Jun 6, 06:39
    buy
    initial